Programming electronic health records to make generic drugs the default choice when physicians write prescriptions may offer one way to reduce unnecessary spending and improve health care value in the face of spiraling U.S. ...
Nov 17, 2014
0
0
Can pain relievers really target a specific part of the body? Are generic medicines inferior to their brand-name counterparts? Are natural medicines always safer then prescription drugs? Can you mix alcohol with a prescription ...
Oct 13, 2014
0
0
(Medical Xpress)—Access to medicines by vulnerable groups in the community, increasing medicine costs, and the demand for new medicines are some of the challenges identified in an independent study of priority medicine ...
Jun 11, 2014
0
0
(Medical Xpress)—The availability, pricing and affordability of three essential asthma medicines varies greatly according to a new study of 52 low-and middle-income countries
Oct 16, 2013
0
0
An Indian pharmaceutical firm said Thursday it would soon launch the world's first vaccine against typhoid which can be given to infants, protecting the most vulnerable victims of the illness.
Aug 29, 2013
0
0
A free trade pact being negotiated by the U.S. and 11 Asia-Pacific nations will impose aggressive intellectual property rules that could restrict access to affordable medicines in developing nations, health activists warned ...
Jul 3, 2013
0
0
Evergreening strategies—where pharmaceutical companies slightly change the formulation of their brand drug into "follow on" drugs by combining formulations or producing slow-release forms, for example, so that they can ...
Jun 4, 2013
0
0
Britain's competition watchdog accused GlaxoSmithKline on Friday of paying off competitors to delay launches of their own versions of GSK's best-selling antidepressant, Seroxat.
Apr 19, 2013
1
0
A US-led Pacific free trade pact faces further delays as a row between Big Pharma and activists supporting access to generic drugs erupts ahead of an October deadline, officials say.
Mar 10, 2013
1
0
Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were ...
Nov 30, 2012
0
0
